ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In-Vitro Colorectal Cancer Screening Tests Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-24A8913
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global In Vitro Colorectal Cancer Screening Tests Market Size Status and Forecast 2022
BUY CHAPTERS

Global In-Vitro Colorectal Cancer Screening Tests Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-24A8913
Report
June 2025
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Alere (Abbott)
Beckman Coulter
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
Qiagen NV
R-Biopharm
Immunostics
Siemens Healthcare

In-Vitro Colorectal Cancer Screening Tests Market Size

In 2024, the global market size of In-Vitro Colorectal Cancer Screening Tests was estimated to be worth US$ 1162 million and is forecast to reach approximately US$ 1682 million by 2031 with a CAGR of 5.5% during the forecast period 2025-2031.

In-Vitro Colorectal Cancer Screening Tests Market

In-Vitro Colorectal Cancer Screening Tests Market

In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.
The industry"s leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-Vitro Colorectal Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Colorectal Cancer Screening Tests.
The In-Vitro Colorectal Cancer Screening Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Colorectal Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Colorectal Cancer Screening Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of In-Vitro Colorectal Cancer Screening Tests Market Report

Report Metric Details
Report Name In-Vitro Colorectal Cancer Screening Tests Market
CAGR 5.5%
Segment by Type
  • Biomarker Tests
  • Fecal Occult Blood Tests
  • CRC DNA Screening Tests
Segment by Application
  • Hospital and Clinics
  • Ambulatory
  • Home Care
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of In-Vitro Colorectal Cancer Screening Tests in global and regional level.
  • Chapter 3: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In-Vitro Colorectal Cancer Screening Tests revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Alere(Abbott) share in In-Vitro Colorectal Cancer Screening Tests Market?

Ans: The industry"s leading producers are Alere(Abbott), Beckman Coulter and Siemens Healthcare, which accounted for 31.59%, 18.71% and 10.67% of revenue in 2019, respectively.

Who are the main players in the In-Vitro Colorectal Cancer Screening Tests Market report?

Ans: The main players in the In-Vitro Colorectal Cancer Screening Tests Market are Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN, R-Biopharm, Immunostics

What are the Application segmentation covered in the In-Vitro Colorectal Cancer Screening Tests Market report?

Ans: The Applications covered in the In-Vitro Colorectal Cancer Screening Tests Market report are Hospital and Clinics, Ambulatory, Home Care

What are the Type segmentation covered in the In-Vitro Colorectal Cancer Screening Tests Market report?

Ans: The Types covered in the In-Vitro Colorectal Cancer Screening Tests Market report are Biomarker Tests, Fecal Occult Blood Tests, CRC DNA Screening Tests

1 Study Coverage
1.1 In-Vitro Colorectal Cancer Screening Tests Product Introduction
1.2 Market by Type
1.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Biomarker Tests
1.2.3 Fecal Occult Blood Tests
1.2.4 CRC DNA Screening Tests
1.3 Market by Application
1.3.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospital and Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size Estimates and Forecasts
2.2 In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2024 Versus 2031
2.2.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Region: 2020-2025
2.2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Region (2026-2031)
2.2.3 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2031)
3.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2031)
3.2.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Biomarker Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application
3.3.2 Fecal Occult Blood Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application
3.3.3 CRC DNA Screening Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application
4 Global In-Vitro Colorectal Cancer Screening Tests by Company
4.1 Global In-Vitro Colorectal Cancer Screening Tests Revenue by Company (2020-2025)
4.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key In-Vitro Colorectal Cancer Screening Tests Companies around the World: Ranking by Revenue
4.3.2 Global In-Vitro Colorectal Cancer Screening Tests Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global In-Vitro Colorectal Cancer Screening Tests Companies Headquarters & Product Type
4.4.1 Global In-Vitro Colorectal Cancer Screening Tests Companies Headquarters
4.4.2 Date of International Companies Enter into In-Vitro Colorectal Cancer Screening Tests Market
4.4.3 Global In-Vitro Colorectal Cancer Screening Tests Companies Product & Service
4.4.4 Biomarker Tests Revenue Market Share of In-Vitro Colorectal Cancer Screening Tests by Company
4.4.5 Fecal Occult Blood Tests Revenue Market Share of In-Vitro Colorectal Cancer Screening Tests by Company
4.4.6 CRC DNA Screening Tests Revenue Market Share of In-Vitro Colorectal Cancer Screening Tests by Company
4.5 Global In-Vitro Colorectal Cancer Screening Tests Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Alere(Abbott)
5.1.1 Alere(Abbott) Corporation Information
5.1.2 Alere(Abbott) Description, Business Overview
5.1.3 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Products Offered
5.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.1.5 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.1.6 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.1.7 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.1.8 Alere(Abbott) Recent Developments
5.2 Beckman Coulter
5.2.1 Beckman Coulter Corporation Information
5.2.2 Beckman Coulter Description, Business Overview
5.2.3 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Products Offered
5.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.2.5 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.2.6 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.2.7 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.2.8 Beckman Coulter Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Corporation Information
5.3.2 Siemens Healthcare Description, Business Overview
5.3.3 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Products Offered
5.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.3.5 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.3.6 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.3.7 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.3.8 Siemens Healthcare Recent Developments
5.4 Eiken Chemical
5.4.1 Eiken Chemical Corporation Information
5.4.2 Eiken Chemical Description, Business Overview
5.4.3 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Products Offered
5.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.4.5 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.4.6 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.4.7 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.4.8 Eiken Chemical Recent Developments
5.5 Hitachi Chemical (Kyowa Medex)
5.5.1 Hitachi Chemical (Kyowa Medex) Corporation Information
5.5.2 Hitachi Chemical (Kyowa Medex) Description, Business Overview
5.5.3 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Products Offered
5.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.5.5 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.5.6 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.5.7 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.5.8 Hitachi Chemical (Kyowa Medex) Recent Developments
5.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
5.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Corporation Information
5.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Description, Business Overview
5.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Products Offered
5.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.6.6 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.6.7 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.6.8 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
5.7 Sysmex
5.7.1 Sysmex Corporation Information
5.7.2 Sysmex Description, Business Overview
5.7.3 Sysmex In-Vitro Colorectal Cancer Screening Tests Products Offered
5.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.7.5 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.7.6 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.7.7 Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.7.8 Sysmex Recent Developments
5.8 QIAGEN
5.8.1 QIAGEN Corporation Information
5.8.2 QIAGEN Description, Business Overview
5.8.3 QIAGEN In-Vitro Colorectal Cancer Screening Tests Products Offered
5.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.8.5 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.8.6 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.8.7 QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.8.8 QIAGEN Recent Developments
5.9 R-Biopharm
5.9.1 R-Biopharm Corporation Information
5.9.2 R-Biopharm Description, Business Overview
5.9.3 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Products Offered
5.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.9.5 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.9.6 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.9.7 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.9.8 R-Biopharm Recent Developments
5.10 Immunostics
5.10.1 Immunostics Corporation Information
5.10.2 Immunostics Description, Business Overview
5.10.3 Immunostics In-Vitro Colorectal Cancer Screening Tests Products Offered
5.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue and Gross Margin (2020-2025)
5.10.5 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue by Product in 2024
5.10.6 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue by Application in 2024
5.10.7 Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue by Geographic Area in 2024
5.10.8 Immunostics Recent Developments
6 North America
6.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2020-2031
6.2 North America In-Vitro Colorectal Cancer Screening Tests Market Facts & Figures by Country (2020-2031)
6.3 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025)
6.4 North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2020-2031
7.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025)
7.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025)
8 Europe
8.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2020-2031
8.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Facts & Figures by Country (2020-2031)
8.3 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025)
8.4 Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2020-2031
9.2 Latin America In-Vitro Colorectal Cancer Screening Tests Market Facts & Figures by Country (2020-2031)
9.3 Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025)
9.4 Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America In-Vitro Colorectal Cancer Screening Tests Market Size YoY Growth 2020-2031
10.2 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025)
10.4 Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 In-Vitro Colorectal Cancer Screening Tests Supply Chain Analysis
11.2 In-Vitro Colorectal Cancer Screening Tests Key Raw Materials and Upstream Suppliers
11.3 In-Vitro Colorectal Cancer Screening Tests Clients Analysis
11.4 In-Vitro Colorectal Cancer Screening Tests Sales Channel and Sales Model Analysis
11.4.1 In-Vitro Colorectal Cancer Screening Tests Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 In-Vitro Colorectal Cancer Screening Tests Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 In-Vitro Colorectal Cancer Screening Tests Distributors
12 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
12.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
12.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers
12.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
12.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Alere (Abbott)
Beckman Coulter
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
Qiagen NV
R-Biopharm
Immunostics
Siemens Healthcare
List of Tables
 Table 1. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global In-Vitro Colorectal Cancer Screening Tests Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global In-Vitro Colorectal Cancer Screening Tests Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. In-Vitro Colorectal Cancer Screening Tests Revenue by Company (2020-2025) & (US$ Million)
 Table 11. In-Vitro Colorectal Cancer Screening Tests Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (US$ Million) in 2024
 Table 13. Global In-Vitro Colorectal Cancer Screening Tests Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global In-Vitro Colorectal Cancer Screening Tests by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Colorectal Cancer Screening Tests as of 2024)
 Table 15. Global In-Vitro Colorectal Cancer Screening Tests Companies Headquarters
 Table 16. Date of International Companies Enter into In-Vitro Colorectal Cancer Screening Tests Market
 Table 17. Global In-Vitro Colorectal Cancer Screening Tests Companies Product & Service
 Table 18. Global In-Vitro Colorectal Cancer Screening Tests Mergers & Acquisitions, Expansion Plans
 Table 19. Alere(Abbott) Corporation Information
 Table 20. Alere(Abbott) Description and Business Overview
 Table 21. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product
 Table 22. Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Alere(Abbott) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 24. Alere(Abbott) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 25. Alere(Abbott) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 26. Alere(Abbott) Recent Developments
 Table 27. Beckman Coulter Corporation Information
 Table 28. Beckman Coulter Description and Business Overview
 Table 29. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product
 Table 30. Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Beckman Coulter Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 32. Beckman Coulter Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 33. Beckman Coulter Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 34. Beckman Coulter Recent Developments
 Table 35. Siemens Healthcare Corporation Information
 Table 36. Siemens Healthcare Description and Business Overview
 Table 37. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product
 Table 38. Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Siemens Healthcare Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 40. Siemens Healthcare Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 41. Siemens Healthcare Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 42. Siemens Healthcare Recent Developments
 Table 43. Eiken Chemical Corporation Information
 Table 44. Eiken Chemical Description and Business Overview
 Table 45. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product
 Table 46. Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Eiken Chemical Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 48. Eiken Chemical Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 49. Eiken Chemical Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 50. Eiken Chemical Recent Developments
 Table 51. Hitachi Chemical (Kyowa Medex) Corporation Information
 Table 52. Hitachi Chemical (Kyowa Medex) Description and Business Overview
 Table 53. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product
 Table 54. Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Hitachi Chemical (Kyowa Medex) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 56. Hitachi Chemical (Kyowa Medex) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 57. Hitachi Chemical (Kyowa Medex) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 58. Hitachi Chemical (Kyowa Medex) Recent Developments
 Table 59. Clinical Genomics Pty Ltd (Quest Diagnostics) Corporation Information
 Table 60. Clinical Genomics Pty Ltd (Quest Diagnostics) Description and Business Overview
 Table 61. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product
 Table 62. Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 64. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 65. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 66. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
 Table 67. Sysmex Corporation Information
 Table 68. Sysmex Description and Business Overview
 Table 69. Sysmex In-Vitro Colorectal Cancer Screening Tests Product
 Table 70. Sysmex In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Sysmex Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 72. Sysmex Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 73. Sysmex Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 74. Sysmex Recent Developments
 Table 75. QIAGEN Corporation Information
 Table 76. QIAGEN Description and Business Overview
 Table 77. QIAGEN In-Vitro Colorectal Cancer Screening Tests Product
 Table 78. QIAGEN In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. QIAGEN Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 80. QIAGEN Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 81. QIAGEN Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 82. QIAGEN Recent Developments
 Table 83. R-Biopharm Corporation Information
 Table 84. R-Biopharm Description and Business Overview
 Table 85. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product
 Table 86. R-Biopharm In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. R-Biopharm Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 88. R-Biopharm Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 89. R-Biopharm Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 90. R-Biopharm Recent Developments
 Table 91. Immunostics Corporation Information
 Table 92. Immunostics Description and Business Overview
 Table 93. Immunostics In-Vitro Colorectal Cancer Screening Tests Product
 Table 94. Immunostics In-Vitro Colorectal Cancer Screening Tests Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Immunostics Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Product in 2024
 Table 96. Immunostics Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Application in 2024
 Table 97. Immunostics Revenue Proportion of In-Vitro Colorectal Cancer Screening Tests by Geographic Area in 2024
 Table 98. Immunostics Recent Developments
 Table 99. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 100. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 101. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 102. North America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 103. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2020-2025) & (US$ Million)
 Table 104. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Region (2026-2031) & (US$ Million)
 Table 105. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 106. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 107. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 108. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 109. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 110. Europe In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 112. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 113. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 114. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 115. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2020-2025) & (US$ Million)
 Table 116. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Country (2026-2031) & (US$ Million)
 Table 117. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Type (2020-2025) & (US$ Million)
 Table 118. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue by Application (2020-2025) & (US$ Million)
 Table 119. In-Vitro Colorectal Cancer Screening Tests Key Raw Materials, Industry Status and Trend
 Table 120. In-Vitro Colorectal Cancer Screening Tests Key Raw Materials and Upstream Suppliers
 Table 121. In-Vitro Colorectal Cancer Screening Tests Clients Status and Trend
 Table 122. In-Vitro Colorectal Cancer Screening Tests Typical Clients
 Table 123. In-Vitro Colorectal Cancer Screening Tests Distributors
 Table 124. In-Vitro Colorectal Cancer Screening Tests Market Trends
 Table 125. In-Vitro Colorectal Cancer Screening Tests Market Drivers
 Table 126. In-Vitro Colorectal Cancer Screening Tests Market Challenges
 Table 127. In-Vitro Colorectal Cancer Screening Tests Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources


List of Figures
 Figure 1. In-Vitro Colorectal Cancer Screening Tests Product Picture
 Figure 2. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type in 2024 & 2031
 Figure 4. Biomarker Tests Product Picture
 Figure 5. Fecal Occult Blood Tests Product Picture
 Figure 6. CRC DNA Screening Tests Product Picture
 Figure 7. Global In-Vitro Colorectal Cancer Screening Tests Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application in 2024 & 2031
 Figure 9. Hospital and Clinics
 Figure 10. Ambulatory
 Figure 11. Home Care
 Figure 12. In-Vitro Colorectal Cancer Screening Tests Report Years Considered
 Figure 13. Global In-Vitro Colorectal Cancer Screening Tests Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031) & (US$ Million)
 Figure 15. Global In-Vitro Colorectal Cancer Screening Tests Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2020-2031)
 Figure 17. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. Biomarker Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Fecal Occult Blood Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application, 2024 VS 2031
 Figure 21. CRC DNA Screening Tests of In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application, 2024 VS 2031
 Figure 22. In-Vitro Colorectal Cancer Screening Tests Revenue Share by Company (2024)
 Figure 23. In-Vitro Colorectal Cancer Screening Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Biomarker Tests Revenue Proportion by Company in 2024
 Figure 25. Fecal Occult Blood Tests Revenue Proportion by Company in 2024
 Figure 26. CRC DNA Screening Tests Revenue Proportion by Company in 2024
 Figure 27. North America In-Vitro Colorectal Cancer Screening Tests Revenue 2020-2031 (US$ Million)
 Figure 28. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2025)
 Figure 29. North America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2025)
 Figure 30. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue 2020-2031 (US$ Million)
 Figure 31. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Region (2020-2031)
 Figure 32. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2025)
 Figure 33. Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2025)
 Figure 34. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2020-2031)
 Figure 36. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2025)
 Figure 37. Europe In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2025)
 Figure 38. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2020-2031)
 Figure 40. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2025)
 Figure 41. Latin America In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2025)
 Figure 42. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Country (2020-2031)
 Figure 44. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Type (2020-2025)
 Figure 45. Middle East and Africa In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Application (2020-2025)
 Figure 46. In-Vitro Colorectal Cancer Screening Tests Supply Chain (Upstream and Downstream Market)
 Figure 47. Global Production Market Share of In-Vitro Colorectal Cancer Screening Tests Raw Materials by Region in 2024
 Figure 48. In-Vitro Colorectal Cancer Screening Tests Distribution Channels
 Figure 49. Global In-Vitro Colorectal Cancer Screening Tests Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 50. Global In-Vitro Colorectal Cancer Screening Tests Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

In Vitro Colorectal Cancer Testing Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Colorectal Cancer Screening Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colorectal Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colorectal Cancer Screening Test Market Research Report 2024
Global In Vitro Cancer Screening Tests Kits Market Research Report 2024
Global Precision Cancer Tests Market Research Report 2024
In Vitro Diagnostic Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global In Vitro Screening Market Research Report 2025
Colorectal Cancer Diagnostics Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Cancer Diagnostic Reagent Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic IVD Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostics IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In vitro Diagnostic Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Colorectal Cancer Test Kit Market Research Report 2025
Precision Cancer Diagnostic Tests Market
In Vitro Diagnostics Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In Vitro Diagnostic IVD Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Colorectal Cancer Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Early Detection and Screening Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
In vitro Diagnostics Enzymes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions